This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Dec 20;23(36):9433-4; author reply 9433-5.

doi: 10.1200/JCO.2005.04.1376.

Bone loss with exemestane: Is the jury still out?

Angela M Cheung, George Tomlinson, Paul E Goss

PMID: 16361646
DOI: 10.1200/JCO.2005.04.1376

Comment

Bone loss with exemestane: Is the jury still out?

Angela M Cheung et al. J Clin Oncol. 2005.

. 2005 Dec 20;23(36):9433-4; author reply 9433-5.

doi: 10.1200/JCO.2005.04.1376.

Authors

Angela M Cheung, George Tomlinson, Paul E Goss

PMID: 16361646
DOI: 10.1200/JCO.2005.04.1376

No abstract available

PubMed Disclaimer

Comment on

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.
Lønning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J, Polli A, Massimini G. Lønning PE, et al. J Clin Oncol. 2005 Aug 1;23(22):5126-37. doi: 10.1200/JCO.2005.07.097. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983390 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

44917/CAPMC/ CIHR/Canada

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information